Cargando…

α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease

Progressive degeneration of dopaminergic neurons, immune activation, and α-synuclein pathology characterize Parkinson’s disease (PD). We previously reported that unilateral intranigral injection of recombinant adeno-associated viral (rAAV) vectors encoding wild-type human α-synuclein produced a rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stokholm, Kathrine, Thomsen, Majken Borup, Phan, Jenny-Ann, Møller, Line K., Bay-Richter, Cecilie, Christiansen, Søren H., Woldbye, David P. D., Romero-Ramos, Marina, Landau, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698691/ https://www.ncbi.nlm.nih.gov/pubmed/34944691 http://dx.doi.org/10.3390/biomedicines9121876

Ejemplares similares

Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson’s disease
por: Phan, Jenny-Ann, et al.
Publicado: (2017)

Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies
por: Real, Caroline Cristiano, et al.
Publicado: (2023)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
por: Bisaglia, Marco, et al.
Publicado: (2010)

Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
por: Aniszewska, Agata, et al.
Publicado: (2022)

Striatal Dopamine Transmission Is Subtly Modified in Human A53Tα-Synuclein Overexpressing Mice
por: Platt, Nicola J., et al.
Publicado: (2012)

A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice
por: Kurz, Alexander, et al.
Publicado: (2010)

Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease
por: Matrone, Carmela, et al.
Publicado: (2016)

Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
por: Post, Michael R., et al.
Publicado: (2018)

Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
por: Niu, Haichen, et al.
Publicado: (2018)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
por: Zambon, Federico, et al.
Publicado: (2019)

A Molotov cocktail: dopamine and α-synuclein
por: Tuma, Rabiya
Publicado: (2002)

Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs
por: Latawiec, Diane, et al.
Publicado: (2010)

Dopamine-Induced Conformational Changes in Alpha-Synuclein
por: Outeiro, Tiago F., et al.
Publicado: (2009)

Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease
por: Banerjee, Kalpita, et al.
Publicado: (2014)

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
por: Kaul, Tiffany, et al.
Publicado: (2011)

PS15. Can gene therapy treat anxiety? – Overexpression of Neuropeptide S using adeno-associated viral vectors
por: Tillmann, S, et al.
Publicado: (2016)

Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2018)

Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson’s Disease Patient-Specific Dopamine Neurons
por: Ferrer-Lorente, Raquel, et al.
Publicado: (2021)

Substrate-induced conformational dynamics of the dopamine transporter
por: Nielsen, Anne Kathrine, et al.
Publicado: (2019)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation
por: Lee, Seongmi, et al.
Publicado: (2017)

Dopamine-Mediated Oxidation of Methionine 127 in α-Synuclein Causes Cytotoxicity and Oligomerization of α-Synuclein
por: Nakaso, Kazuhiro, et al.
Publicado: (2013)

Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
por: Lohmann, Stephanie, et al.
Publicado: (2022)

Retraction Note: Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
por: Niu, Haichen, et al.
Publicado: (2022)

Anxiolytic-Like Effects of Increased Ghrelin Receptor Signaling in the Amygdala
por: Jensen, Morten, et al.
Publicado: (2015)

Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
por: Duce, James A., et al.
Publicado: (2017)

A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
por: Björklund, Anders, et al.
Publicado: (2022)

Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
por: Ferreira, Sara A., et al.
Publicado: (2018)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Gene Therapy for Parkinson’s Disease, An Update
por: Axelsen, Tobias M., et al.
Publicado: (2018)

Combined In Vivo Microdialysis and PET Studies to Validate [(11)C]Yohimbine Binding as a Marker of Noradrenaline Release
por: Landau, Anne Marlene, et al.
Publicado: (2023)

Overexpression-Induced α-Synuclein Brain Spreading
por: Pinto-Costa, Rita, et al.
Publicado: (2022)

5-HT(2A) Receptor Binding in the Frontal Cortex of Parkinson's Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2016)

Dopamine and α-synuclein dysfunction in Smad3 null mice
por: Tapia-González, Silvia, et al.
Publicado: (2011)

Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States
por: Illes-Toth, Eva, et al.
Publicado: (2013)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
por: Zou, Wenyan, et al.
Publicado: (2019)

Nano-imaging trace elements at organelle levels in substantia nigra overexpressing α-synuclein to model Parkinson’s disease
por: Lemelle, Laurence, et al.
Publicado: (2020)

Isotope-reinforced polyunsaturated fatty acids improve Parkinson’s disease-like phenotype in rats overexpressing α-synuclein
por: Beal, M. Flint, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cacg1ash8555jvc11um56rsdnm